Maiva Pharma, a Bengaluru CDMO, raised $130m from Morgan Stanley and India Life Sciences for a new manufacturing facility in Hosur, India to produce sterile dosage forms.

Maiva Pharma, a Bengaluru-based CDMO, raised Rs 1,000 crore ($130 million) from Morgan Stanley Private Equity Asia and India Life Sciences Fund. The funds will be used to establish a new manufacturing facility near Hosur, India, with capabilities in various sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. This investment marks Maiva's first private equity fundraise and will help the company expand in the rapidly growing Indian healthcare sector.

May 02, 2024
7 Articles